Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHA-PPQ vs AL for Uncomplicated Malaria in Kenya
NCT01899820Phase 3Unknown
- Start
- Apr 2013
- Primary completion
- Jun 2014
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dihydroartemisinin + piperaquine in malaria. Primary endpoint: PCR-corrected Adequate Clinical and Parasitological Response at Day 42. Status: unknown.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT01899820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01899820.